A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars. [electronic resource]
Producer: 20160523Description: 1166-74 p. digitalISSN:- 1399-0020
- Adolescent
- Adult
- Cyclooxygenase 2 Inhibitors -- therapeutic use
- Double-Blind Method
- Etoricoxib
- Female
- Humans
- Male
- Mandible -- surgery
- Molar, Third -- surgery
- Pain Measurement
- Pain, Postoperative -- prevention & control
- Placebos
- Pyridines -- therapeutic use
- Sulfones -- therapeutic use
- Tooth Extraction
- Tooth, Impacted -- surgery
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.